Pacira BioSciences, Inc. (NASDAQ: PCRX) witnessed a sharp surge in its stock price following the resolution of its long-standing patent disputes. In after-hours trading, shares
There are certain notable prospects for Pacira to become a mega biosciences firm in the next few years. The COVID-19 pandemic has increased the significance
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.